Journals
Publish with us
Publishing partnerships
About us
Blog
BioMed Research International
+
Journal Menu
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Submit
BioMed Research International
/
2014
/
Article
/
Tab 12
Research Article
Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer
Table 12
The results of up- and downregulated target genes within
-communities using ES and cMap
value as the effect size.
Effect size
ES
Early-stage
Up-community gene
Down-community gene
FEN1, IDH1, PSMB2, PSMB5, RPL26L1
NR3C1, PPARG
Late-stage
PSMB2
NR3C1, PPARG
value < 0.1
Early-stage
EZH2, FEN1, IDH1, and RPL26L1
NR3C1, PPARG
Late-stage
Not available
NR3C1, PPARG